FULLER T, Havers F, Xu C, Fang LQ, et al. Identifying areas with a high risk of human infection with the avian influenza a (H7N9) virus in east asia. J Infect. 2014 Mar 15. pii: S0163-4453(14)00076.
OBJECTIVES:
The rapid emergence, spread, and disease severity of avian influenza A(H7N9) in China has prompted concerns about a possible pandemic and regional spread in the coming months. The objective of this study was to predict the risk of future human infections with H7N9 in China and neighboring countries by assessing the association between H7N9 cases at sentinel hospitals and putative agricultural, climatic, and demographic risk factors.
METHODS:
This cross-sectional study used the locations of H7N9 cases and negative cases from China´s influenza-like illness surveillance network. After identifying H7N9 risk factors with logistic regression, we used Geographic Information Systems (GIS) to construct predictive maps of H7N9 risk across Asia.
RESULTS:
Live bird market density was associated with human H7N9 infections reported in China from March-May 2013. Based on these cases, our model accurately predicted the virus´ spread into Guangxi autonomous region in February 2014. Outside China, we find there is a high risk that the virus will spread to northern Vietnam, due to the import of poultry from China.
CONCLUSIONS:
Our risk map can focus efforts to improve surveillance in poultry and humans, which may facilitate early identification and treatment of human cases.
See Also:
Latest articles in those days:
- Global pattern and determinant for interaction of seasonal influenza viruses 13 hours ago
- Spatio-temporal dynamics and drivers of highly pathogenic avian influenza H5N1 in Chile 2 days ago
- [preprint] Avian Influenza Virus Infections in Felines: A Systematic Review of Two Decades of Literature 2 days ago
- Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe 2 days ago
- Assessment of potential adverse events following the 2022-2023 seasonal influenza vaccines among U.S. adults aged 65 years and older 2 days ago
[Go Top] [Close Window]